Clinical trials
Withdrawn Phase 1 Esophageal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Kejing Biotechnology Co., Ltd. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Maastricht Radiation Oncology | 1 |
| NYU Langone Health | 1 |
| OHSU Knight Cancer Institute | 1 |
| Sunshine Lake Pharma Co., Ltd. | 1 |
| Themis Bioscience GmbH | 1 |
| University of California, San Francisco | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 9 |
| Stomach Neoplasms | 4 |
| Colorectal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Cholangiocarcinoma | 1 |
| Colonic Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.